Osiris Therapeutics Inc. (OSIR) Stock Marches to Vanguard of Stem Cell Therapeutics Business Segment
Stem cell therapy has already changed the face of modern health care. A cascade of additional applications is under various stages of development. The chances of deleterious side-effects are relatively less with stem cell technologies. Unlike chemical drugs of the last century, genetic interventions are targeted and closer to natural healing mechanisms. However, the technologies involved for commercial operations are nearly impossible to access, leaving the few successful corporations, like this one from Columbia, MD, with wide and deep technical moats. The stock price has never crossed $16, and the market capitalization is still below $500 million. However, the company…